Chevron Left
Zurück zu Medikamentenentwicklung

Bewertung und Feedback des Lernenden für Medikamentenentwicklung von University of California San Diego

2,077 Bewertungen

Über den Kurs

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (, Drug Development and Drug Commercialization ( We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....



15. Okt. 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.


24. Mai 2020

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

Filtern nach:

276 - 300 von 413 Bewertungen für Medikamentenentwicklung

von sowjanya g

4. März 2019

von Mohammad j s

23. Sep. 2017

von josephmary

18. Juni 2020

von K V S R

24. Mai 2020

von Nwando O

9. Feb. 2020

von Sailaja B

10. Juli 2019

von Alan Q

17. Mai 2018

von Arman A

8. Mai 2020

von ananda

4. Mai 2021

von Valery T

27. Mai 2018

von Venkat R R

25. Juni 2020

von miranda w

18. Feb. 2020

von Aedrian A

16. Jan. 2021

von Vanja T

22. Feb. 2018

von Brendan D

15. Okt. 2017

von Güliz T B

25. Feb. 2020

von Jamal E

4. Juli 2021


12. Mai 2020

von Momchil N

16. Feb. 2020

von George W

5. Juli 2019

von Ashwini K

17. Juli 2017

von Abram S

24. Juni 2020

von Jonathan P

3. Apr. 2020

von Amjad N

3. März 2019

von Subramanian K

2. Sep. 2017